查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402024

到 2030 年輔助生殖技術的市場預測：按產品、程序、技術、最終用戶和地區進行的全球分析

Assisted Reproductive Technology Market Forecasts to 2030 - Global Analysis By Product, Procedure, Technology, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球輔助生殖技術市場規模為 290.1 億美元，預測期內複合年成長率為 10.4%，到 2030 年將達到 579.9 億美元。

輔助生殖技術是指在傳統方法不成功的情況下旨在幫助個人和夫婦懷孕的各種醫療程序。子宮內人工授精 (IUI)、體外受精 (IVF) 和生育藥物都屬於這個通用術語。 ART 也大大改變了生殖醫學，為那些飽受不孕和懷孕困擾的人們帶來了希望。

根據國立食品科學研究所2022年12月發布的女性不孕資料顯示，過去生產過活產的女性中，有11%將無法再次生下活產，而全球整體要到20歲才能再生產一個活產嬰兒。據說，44歲至44歲的女性中有2%根本無法生產活產嬰兒。

不孕率上升

不孕率不斷上升，其原因很大程度上與以高壓力、久坐行為和環境變數為特徵的現代生活方式有關。此外，子宮內膜異位症和卵巢症候群（PCOS）等疾病也會顯著增加不孕症的發生率。隨著越來越多的人和夫婦難以自然受孕，對輔助生殖技術的需求不斷增加，這凸顯了這些干預措施作為治療方法不孕症的必要性。

成功率有限

儘管由於技術進步，ART，尤其是IVF的成功率有所提高，但妊娠並不能保證。此外，對治療、年齡和基礎醫療狀況反應的個體差異可能會限制這些干預措施的有效性。對於那些考慮 ART 的人來說，固有的不確定性和可變的成功率仍然是主要的阻礙力。

擴大冷凍保存的用途

卵子、精子和胚胎等生殖材料可以透過玻璃化等冷凍保存技術延長存活時間。此外，這可以更好地與人們的生活決策和環境同步。保存生育能力以供日後使用的能力擴大了冷凍保存的用途，幫助人們更靈活地規劃他們的家庭。

多胎妊娠的風險

某些 ART 手術可能導致多胎妊娠，從而使孕產婦和胎兒的健康面臨風險。此外，早產和低出生體重是多胎妊娠導致母親和胎兒健康風險增加的兩種併發症。在現場，在不犧牲高成功率的情況下降低這些風險是一個持續的挑戰。

COVID-19 的影響

輔助生殖技術市場受到了COVID-19大流行的影響。不孕症治療的暫時下降可能是由於關閉措施和對非必要醫療程序的限制，該行業可能會遭受暫時的挫折。然而，隨著衛生系統適應新常態，對 ART 服務的需求顯著增加。這場流行病引起了人們對生殖健康重要性的關注，因為人們重新評估了他們的優先事項，也許更加關注計劃生育。此外，虛擬諮詢和遠端醫療的改進為不孕症治療提供了更方便、更平易近人的方法。

體外受精（IVF）產業預計將在預測期內成為最大的產業

體外受精（IVF）是輔助生殖技術中最大的市場佔有率。體外受精（IVF）涉及在體外使卵子與精子受精，並將產生的胚胎植入子宮。由於其適應性和高成功率，該技術已變得非常流行，現在是單身人士和患有不孕不育的夫婦的選擇。此外，透過體外受精治療不孕症對於男性因素不孕症、輸卵管疾病和不明原因不孕症特別成功。

預計生育診所領域在預測期內複合年成長率最高

複合年成長率最高的細分市場是生育診所。 IVF和IUI等輔助生殖技術以及其他不孕症治療是生育診所的重點。我們也提供生殖健康服務。此外，由於對這些專業服務的需求不斷增加以及 ART 程序和技術的改進，生育診所市場正在經歷強勁成長。此外，生育診所提供專門且專注的生殖醫學方法，吸引尋求深入了解生育治療的個人和夫妻。

佔有率最大的地區：

歐洲地區預計將佔據全球輔助生殖技術市場的最大佔有率。英國、德國、法國、西班牙等歐洲國家醫療體系完善，不孕症治療的接受度不斷提高。大量的 ART 治療得到該地區先進的法規結構、熟練的生殖專家和最先進的生育診所網路的支持。此外，歐洲仍然是全球輔助生殖技術市場的主要參與企業，提供廣泛的生殖服務並推動生殖健康領域的改善。

複合年成長率最高的地區：

在全球輔助生殖技術市場中，亞太地區預期複合年成長率最高。該地區（包括中國、印度和日本）對生殖保健的需求顯著增加。亞太地區的高成長歸因於多種因素，包括不孕率上升、輔助生殖技術的接受度提高以及醫療基礎設施的進步。此外，政府獎勵計畫和公眾對計劃生育意識的改變也推動了亞太地區ART市場的快速擴張。

免費客製化服務

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球輔助生殖科技市場：依產品

  • 介紹
  • 裝置
    • 精子分離系統
    • 冷凍系統
    • 孵化器
    • 影像系統
    • 抽卵子泵
    • 櫥櫃
    • 顯微操作器
    • 雷射系統
  • 配件和一次性用品
  • 試劑和介質
    • 冷凍保存介質
    • 精液處理培養基
    • 卵子處理培養基
    • 胚胎培養液
  • 其他產品

第6章全球輔助生殖技術市場：依程序

  • 介紹
  • 新的捐贈者
  • 新鮮的非捐贈者
  • 冷凍供體
  • 冷凍非捐贈者
  • 胚胎/卵子庫
  • 其他治療

第7章全球輔助生殖科技市場：依科技分類

  • 介紹
  • 體外受精（IVF）
    • 顯微授精和胞漿內單一精子注射 (ICSI)
    • 無 ICSI 的 IVF
  • 人工授精 - 子宮內授精 (AI-IUI)
  • 冷凍胚胎交換（FER）
  • 代理孕母
  • 誘導排卵
  • 其他技術

第8章全球輔助生殖技術市場：依最終用戶分類

  • 介紹
  • 醫院
  • 不孕不育治療診所
  • 手術中心
  • 臨床研究所
  • 其他最終用戶

第9章全球輔助生殖技術市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Ferring BV
  • Apollo Hospitals Enterprise Ltd.
  • INVO Bioscience
  • Laboratoire CCD
  • Nidacon International AB
  • Fujifilm Holdings Corporation
  • Bloom Fertility Centre
  • Inception Sciences, Inc.
  • Thermo Fisher Scientific, Inc
  • Oxford Gene Technology Ip Ltd
  • Vitrolife AB
  • California Cryobank
  • Hamilton Thorne Inc.
  • Merck KGaA
  • CooperSurgical Inc.
  • OvaScience Inc.
Product Code: SMRC24544

According to Stratistics MRC, the Global Assisted Reproductive Technology (ART) Market is accounted for $29.01 billion in 2023 and is expected to reach $57.99 billion by 2030 growing at a CAGR of 10.4% during the forecast period. Assisted Reproductive Technology (ART) describes a variety of medical treatments intended to help individuals or couples become pregnant in cases where conventional methods are not successful. Intrauterine insemination (IUI), in vitro fertilization (IVF), and fertility drugs are all included under this general term. Moreover, reproductive medicine has changed dramatically as a result of ART, which gives hope to those who are infertile or have trouble getting pregnant.

According to the data published on female infertility in the National Library of Medicines in December 2022, globally, 11% of women who had a previous live birth were unable to have another, and 2% of women aged 20 to 44 were unable to have any live births at all.

Market Dynamics:

Driver:

Growing rates of infertility

Infertility rates are rising, and the causes are largely related to modern lifestyles characterized by high levels of stress, sedentary behavior, and environmental variables. Additionally, medical disorders like endometriosis and polycystic ovarian syndrome (PCOS) greatly raise the incidence of infertility. The need for assisted reproductive technology (ART) is growing as more people and couples struggle to conceive naturally, highlighting these interventions as essential remedies for fertility problems.

Restraint:

Restricted success rates

Even though success rates for ART procedures-particularly in vitro fertilization-have increased due to technological advancements, pregnancy is not a given with these procedures. Furthermore, the effectiveness of these interventions may be limited by individual differences in response to treatments as well as by age and underlying medical conditions. For those considering ART, the fact that there are inherent uncertainties and varying success rates continues to be a major deterrent.

Opportunity:

Increasing cryopreservation's uses

Reproductive materials, such as eggs, sperm, and embryos, can have their viability extended through cryopreservation techniques like vitrification. Moreover, better synchronization with people's life decisions and circumstances is made possible by this. With the ability to store fertility for later use, cryopreservation's growing applications help people plan their families with more flexibility.

Threat:

Multiple pregnancy risks

The health of the mother and fetus are at risk due to the possibility of multiple pregnancies that are linked to certain ART procedures. Furthermore, preterm birth and low birth weight are two complications that increase health risks for mothers and their unborn children when they result from multiple pregnancies. In the field, reducing these risks without sacrificing high success rates is an ongoing challenge.

COVID-19 Impact:

The market for assisted reproductive technologies (ART) has been impacted by the COVID-19 pandemic. One could argue that the industry suffered a temporary setback when lockdowns and restrictions on non-essential medical procedures caused a temporary decline in fertility treatments. Nevertheless, there has been a noticeable uptick in demand for ART services as healthcare systems have adjusted to the new normal. Due to people re-evaluating their priorities and perhaps becoming more interested in family planning, the pandemic brought attention to the significance of reproductive health. Furthermore, improvements in virtual consultations and telehealth emerged as a benefit, providing a more convenient and approachable method of fertility treatment.

The In Vitro-fertilization (IVF) segment is expected to be the largest during the forecast period

In vitro fertilization (IVF) is the market segment with the largest share within Assisted Reproductive Technologies (ART). During in vitro fertilization (IVF), an egg is fertilized with sperm outside of the body, and the resultant embryo is then inserted into the uterus. Due to its adaptability and high success rates, this technique has become very popular and is now the preferred choice for singles and couples dealing with infertility issues. Moreover, when it comes to male factor infertility, fallopian tube disorders, and infertility that remains unexplained, infertility treatment with IVF is especially successful.

The Fertility Clinics segment is expected to have the highest CAGR during the forecast period

The market segment with the highest CAGR is fertility clinics. Providers of assisted reproductive technologies (ART), such as IVF and IUI, as well as other fertility treatments, are the focus of fertility clinics. They also offer complete reproductive healthcare services. In addition, the fertility clinic market has experienced strong growth due to the rising demand for these specialized services as well as improvements in ART procedures and technology. Additionally, a committed and targeted approach to reproductive care is provided by fertility clinics, which attract individuals and couples looking for in-depth knowledge of infertility treatments.

Region with largest share:

The largest share of the market for assisted reproductive technology (ART) worldwide is predicted to go to the European region. Well-established healthcare systems and a growing acceptance of fertility treatments are features of European nations like the United Kingdom, Germany, France, and Spain. A vast array of ART procedures are supported by the region's progressive regulatory frameworks, skilled reproductive specialists, and network of cutting-edge fertility clinics. Furthermore, Europe is still a major player in the global ART market, offering a wide range of reproductive services and encouraging improvements in the field of reproductive medicine.

Region with highest CAGR:

In the global assisted reproductive technology (ART) market, the Asia-Pacific region is projected to have the highest CAGR. This region, which includes China, India, and Japan, has seen a notable increase in the demand for reproductive treatments. The high growth in Asia-Pacific is attributed to a number of factors, including rising rates of infertility, rising acceptance of assisted reproductive technologies, and advancements in healthcare infrastructure. Additionally, encouraging government programs and shifting public perceptions of family planning are factors driving the rapid expansion of the ART market in Asia-Pacific.

Key players in the market:

Some of the key players in Assisted Reproductive Technology (ART) market include Ferring B.V., Apollo Hospitals Enterprise Ltd., INVO Bioscience, Laboratoire CCD, Nidacon International AB, Fujifilm Holdings Corporation, Bloom Fertility Centre, Inception Sciences, Inc., Thermo Fisher Scientific, Inc, Oxford Gene Technology Ip Ltd, Vitrolife AB, California Cryobank, Hamilton Thorne Inc., Merck KGaA, CooperSurgical Inc. and OvaScience Inc.

Key Developments:

In November 2023, Apollo Hospitals Enterprise Limited will invest around Rs 3,435 crore over the next three years to add 2,300 beds in metros and major cities in different parts of the country. The leading healthcare chain is also looking at Operations and Management agreements overseas in Indonesia and Tanzania, though it will not be investing for the purpose.

In November 2023, Japanese conglomerate Fujifilm Holdings Corp and US pharma giant Bristol Myers Squibb Co have agreed to buy the entire output of a 270-MW solar project being developed by National Grid Renewables in Texas. Each of the two companies has sealed virtual power purchase agreements (PPAs) with the Minneapolis, Minnesota-based renewable energy developer, the latter said on Wednesday.

In October 2023, INVO Bioscience, Inc., a healthcare services company focused on expanding access to advanced fertility treatment worldwide, and NAYA Biosciences Inc., a company dedicated to increasing patient access to breakthrough treatments in oncology and regenerative medicine, today jointly announced that they have entered into a definitive merger agreement for INVO to acquire NAYA Biosciences in an all-stock transaction.

Products Covered:

  • Instrument
  • Accessory & Disposable
  • Reagents & Media
  • Other Products

Procedures Covered:

  • Fresh Donor
  • Fresh Nondonor
  • Frozen Donor
  • Frozen Nondonor
  • Embryo/Egg Banking
  • Other Procedures

Technologies Covered:

  • In Vitro-fertilization (IVF)
  • Artificial Insemination - Intrauterine Insemination (AI-IUI)
  • Frozen Embryo Replacement (FER)
  • Surrogacy
  • Ovulation Induction
  • Other Technologies

End Users Covered:

  • Hospital
  • Fertility Clinics
  • Surgical Center
  • Clinical Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Assisted Reproductive Technology (ART) Market, By Product

  • 5.1 Introduction
  • 5.2 Instrument
    • 5.2.1 Sperm Separation System
    • 5.2.2 Cryosystem
    • 5.2.3 Incubator
    • 5.2.4 Imaging System
    • 5.2.5 Ovum Aspiration Pump
    • 5.2.6 Cabinet
    • 5.2.7 Micromanipulator
    • 5.2.8 Laser Systems
  • 5.3 Accessory & Disposable
  • 5.4 Reagents & Media
    • 5.4.1 Cryopreservation Media
    • 5.4.2 Semen Processing Media
    • 5.4.3 Ovum Processing Media
    • 5.4.4 Embryo Culture Media
  • 5.5 Other Products

6 Global Assisted Reproductive Technology (ART) Market, By Procedure

  • 6.1 Introduction
  • 6.2 Fresh Donor
  • 6.3 Fresh Nondonor
  • 6.4 Frozen Donor
  • 6.5 Frozen Nondonor
  • 6.6 Embryo/Egg Banking
  • 6.7 Other Procedures

7 Global Assisted Reproductive Technology (ART) Market, By Technology

  • 7.1 Introduction
  • 7.2 In Vitro-fertilization (IVF)
    • 7.2.1 IVF with Intracytoplasmic Sperm Injection (ICSI)
    • 7.2.2 IVF without ICSI
  • 7.3 Artificial Insemination - Intrauterine Insemination (AI-IUI)
  • 7.4 Frozen Embryo Replacement (FER)
  • 7.5 Surrogacy
  • 7.6 Ovulation Induction
  • 7.7 Other Technologies

8 Global Assisted Reproductive Technology (ART) Market, By End User

  • 8.1 Introduction
  • 8.2 Hospital
  • 8.3 Fertility Clinics
  • 8.4 Surgical Center
  • 8.5 Clinical Research Institutes
  • 8.6 Other End Users

9 Global Assisted Reproductive Technology (ART) Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Ferring B.V.
  • 11.2 Apollo Hospitals Enterprise Ltd.
  • 11.3 INVO Bioscience
  • 11.4 Laboratoire CCD
  • 11.5 Nidacon International AB
  • 11.6 Fujifilm Holdings Corporation
  • 11.7 Bloom Fertility Centre
  • 11.8 Inception Sciences, Inc.
  • 11.9 Thermo Fisher Scientific, Inc
  • 11.10 Oxford Gene Technology Ip Ltd
  • 11.11 Vitrolife AB
  • 11.12 California Cryobank
  • 11.13 Hamilton Thorne Inc.
  • 11.14 Merck KGaA
  • 11.15 CooperSurgical Inc.
  • 11.16 OvaScience Inc.

List of Tables

  • Table 1 Global Assisted Reproductive Technology (ART) Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Assisted Reproductive Technology (ART) Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Assisted Reproductive Technology (ART) Market Outlook, By Instrument (2021-2030) ($MN)
  • Table 4 Global Assisted Reproductive Technology (ART) Market Outlook, By Sperm Separation System (2021-2030) ($MN)
  • Table 5 Global Assisted Reproductive Technology (ART) Market Outlook, By Cryosystem (2021-2030) ($MN)
  • Table 6 Global Assisted Reproductive Technology (ART) Market Outlook, By Incubator (2021-2030) ($MN)
  • Table 7 Global Assisted Reproductive Technology (ART) Market Outlook, By Imaging System (2021-2030) ($MN)
  • Table 8 Global Assisted Reproductive Technology (ART) Market Outlook, By Ovum Aspiration Pump (2021-2030) ($MN)
  • Table 9 Global Assisted Reproductive Technology (ART) Market Outlook, By Cabinet (2021-2030) ($MN)
  • Table 10 Global Assisted Reproductive Technology (ART) Market Outlook, By Micromanipulator (2021-2030) ($MN)
  • Table 11 Global Assisted Reproductive Technology (ART) Market Outlook, By Laser Systems (2021-2030) ($MN)
  • Table 12 Global Assisted Reproductive Technology (ART) Market Outlook, By Accessory & Disposable (2021-2030) ($MN)
  • Table 13 Global Assisted Reproductive Technology (ART) Market Outlook, By Reagents & Media (2021-2030) ($MN)
  • Table 14 Global Assisted Reproductive Technology (ART) Market Outlook, By Cryopreservation Media (2021-2030) ($MN)
  • Table 15 Global Assisted Reproductive Technology (ART) Market Outlook, By Semen Processing Media (2021-2030) ($MN)
  • Table 16 Global Assisted Reproductive Technology (ART) Market Outlook, By Ovum Processing Media (2021-2030) ($MN)
  • Table 17 Global Assisted Reproductive Technology (ART) Market Outlook, By Embryo Culture Media (2021-2030) ($MN)
  • Table 18 Global Assisted Reproductive Technology (ART) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 19 Global Assisted Reproductive Technology (ART) Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 20 Global Assisted Reproductive Technology (ART) Market Outlook, By Fresh Donor (2021-2030) ($MN)
  • Table 21 Global Assisted Reproductive Technology (ART) Market Outlook, By Fresh Nondonor (2021-2030) ($MN)
  • Table 22 Global Assisted Reproductive Technology (ART) Market Outlook, By Frozen Donor (2021-2030) ($MN)
  • Table 23 Global Assisted Reproductive Technology (ART) Market Outlook, By Frozen Nondonor (2021-2030) ($MN)
  • Table 24 Global Assisted Reproductive Technology (ART) Market Outlook, By Embryo/Egg Banking (2021-2030) ($MN)
  • Table 25 Global Assisted Reproductive Technology (ART) Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 26 Global Assisted Reproductive Technology (ART) Market Outlook, By Technology (2021-2030) ($MN)
  • Table 27 Global Assisted Reproductive Technology (ART) Market Outlook, By In Vitro-fertilization (IVF) (2021-2030) ($MN)
  • Table 28 Global Assisted Reproductive Technology (ART) Market Outlook, By IVF with Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 29 Global Assisted Reproductive Technology (ART) Market Outlook, By IVF without ICSI (2021-2030) ($MN)
  • Table 30 Global Assisted Reproductive Technology (ART) Market Outlook, By Artificial Insemination - Intrauterine Insemination (AI-IUI) (2021-2030) ($MN)
  • Table 31 Global Assisted Reproductive Technology (ART) Market Outlook, By Frozen Embryo Replacement (FER) (2021-2030) ($MN)
  • Table 32 Global Assisted Reproductive Technology (ART) Market Outlook, By Surrogacy (2021-2030) ($MN)
  • Table 33 Global Assisted Reproductive Technology (ART) Market Outlook, By Ovulation Induction (2021-2030) ($MN)
  • Table 34 Global Assisted Reproductive Technology (ART) Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 35 Global Assisted Reproductive Technology (ART) Market Outlook, By End User (2021-2030) ($MN)
  • Table 36 Global Assisted Reproductive Technology (ART) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 37 Global Assisted Reproductive Technology (ART) Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 38 Global Assisted Reproductive Technology (ART) Market Outlook, By Surgical Center (2021-2030) ($MN)
  • Table 39 Global Assisted Reproductive Technology (ART) Market Outlook, By Clinical Research Institutes (2021-2030) ($MN)
  • Table 40 Global Assisted Reproductive Technology (ART) Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.